Exploiting Fungal Virulence-Regulating Transcription Factors As Novel Antifungal Drug Targets

PLoS Pathogens

Volumn 11, Issue 7, 2015, Pages

  Bahn, Yong Sun ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BRG1 PROTEIN; CYTOSINE DEAMINASE; DNA BINDING PROTEIN; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; FUNGAL VIRULENCE; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; LUNG INFECTION; NONHUMAN; PATHOGENICITY; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMIC MYCOSIS; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FUNGUS; HUMAN; IMMUNOLOGY; VIRULENCE;

ANIMALS; ANTIFUNGAL AGENTS; DRUG DELIVERY SYSTEMS; FUNGI; HUMANS; TRANSCRIPTION FACTORS; VIRULENCE;

EID: 84938768178     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004936     Document Type: Article

References (34)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Science translational medicine 4: 165rv113.
2. Kong D, Lee MJ, Lin S, Kim ES, (2013) Biosynthesis and pathway engineering of antifungal polyene macrolides in actinomycetes. J Ind Microbiol Biotechnol 40: 529–543. doi: 10.1007/s10295-013-1258-6 23515854
3. Geronikaki A, Fesatidou M, Kartsev V, Macaev F, (2013) Synthesis and biological evaluation of potent antifungal agents. Curr Top Med Chem 13: 2684–2733. 24083791
4. Zaas AK, (2008) Echinocandins: a wealth of choice—how clinically different are they? Curr Opin Infect Dis 21: 426–432. doi: 10.1097/QCO.0b013e328307c79c 18594297
5. Vermes A, Guchelaar HJ, Dankert J, (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46: 171–179. 10933638
6. Imming P, Sinning C, Meyer A, (2006) Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov 5: 821–834. 17016423
7. Koehler AN, (2010) A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol 14: 331–340. doi: 10.1016/j.cbpa.2010.03.022 20395165
8. Berg T, (2008) Inhibition of transcription factors with small organic molecules. Curr Opin Chem Biol 12: 464–471. doi: 10.1016/j.cbpa.2008.07.023 18706517
9. Majmudar CY, Mapp AK, (2005) Chemical approaches to transcriptional regulation. Curr Opin Chem Biol 9: 467–474. 16122970
10. Duffy MJ, Synnott NC, McGowan PM, Crown J, O'Connor D, et al. (2014) p53 as a target for the treatment of cancer. Cancer Treat Rev 40: 1153–1160. doi: 10.1016/j.ctrv.2014.10.004 25455730
11. Nobile CJ, Mitchell AP, (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 1150–1155. 15964282
12. Homann OR, Dea J, Noble SM, Johnson AD, (2009) A phenotypic profile of the Candida albicans regulatory network. PLoS genetics 5: e1000783. doi: 10.1371/journal.pgen.1000783 20041210
13. Noble SM, French S, Kohn LA, Chen V, Johnson AD, (2010) Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet 42: 590–598. doi: 10.1038/ng.605 20543849
14. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, et al. (2008) Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135: 174–188. doi: 10.1016/j.cell.2008.07.046 18854164
15. Jung KW, Yang DH, Maeng S, Lee KT, So YS, et al. (2015) Systematic functional profiling of transcription factor networks in Cryptococcus neoformans. Nat Comms 6: 6757.
16. Maier EJ, Haynes BC, Gish SR, Wang ZA, Skowyra ML, et al. (2015) Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation. Genome Res. 25:690–700. doi: 10.1101/gr.184101.114 25644834
17. Thewes S, (2014) Calcineurin-Crz1 signaling in lower eukaryotes. Eukaryot Cell 13: 694–705. doi: 10.1128/EC.00038-14 24681686
18. O'Meara TR, Holmer SM, Selvig K, Dietrich F, Alspaugh JA, (2013) Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses. mBio 4: e00522–00512. doi: 10.1128/mBio.00522-12 23322637
19. Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA, (2006) Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot Cell 5: 1147–1156. 16835458
20. Nobile CJ, Solis N, Myers CL, Fay AJ, Deneault JS, et al. (2008) Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions. Cell Microbiol 10: 2180–2196. doi: 10.1111/j.1462-5822.2008.01198.x 18627379
21. Lotz H, Sohn K, Brunner H, Muhlschlegel FA, Rupp S, (2004) RBR1, a novel pH-regulated cell wall gene of Candida albicans, is repressed by RIM101 and activated by NRG1. Eukaryot Cell 3: 776–784. 15189998
22. Davis D, Edwards JE, Jr.Mitchell AP, Ibrahim AS, (2000) Candida albicans RIM101 pH response pathway is required for host-pathogen interactions. Infect Immun 68: 5953–5959. 10992507
23. O'Meara TR, Norton D, Price MS, Hay C, Clements MF, et al. (2010) Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog 6: e1000776. doi: 10.1371/journal.ppat.1000776 20174553
24. Jung KW, Strain AK, Nielsen K, Jung KH, Bahn YS, (2012) Two cation transporters Ena1 and Nha1 cooperatively modulate ion homeostasis, antifungal drug resistance, and virulence of Cryptococcus neoformans via the HOG pathway. Fungal Genet Biol 49: 332–345. doi: 10.1016/j.fgb.2012.02.001 22343280
25. Lamb TM, Mitchell AP, (2003) The transcription factor Rim101p governs ion tolerance and cell differentiation by direct repression of the regulatory genes NRG1 and SMP1 in Saccharomyces cerevisiae. Mol Cell Biol 23: 677–686. 12509465
26. Ganguly S, Bishop AC, Xu W, Ghosh S, Nickerson KW, et al. (2011) Zap1 control of cell-cell signaling in Candida albicans biofilms. Eukaryot Cell 10: 1448–1454. doi: 10.1128/EC.05196-11 21890817
27. Chun CD, Brown JC, Madhani HD, (2011) A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans. Cell Host Microbe 9: 243–251. doi: 10.1016/j.chom.2011.02.003 21402362
28. Lu Y, Su C, Liu H, (2012) A GATA transcription factor recruits Hda1 in response to reduced Tor1 signaling to establish a hyphal chromatin state in Candida albicans. PLoS Pathog 8: e1002663. doi: 10.1371/journal.ppat.1002663 22536157
29. Lin CH, Kabrawala S, Fox EP, Nobile CJ, Johnson AD, et al. (2013) Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans. PLoS Pathog 9: e1003305. doi: 10.1371/journal.ppat.1003305 23637598
30. Cleary IA, Lazzell AL, Monteagudo C, Thomas DP, Saville SP, (2012) BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence. Mol Microbiol 85: 557–573. doi: 10.1111/j.1365-2958.2012.08127.x 22757963
31. Du H, Guan G, Xie J, Sun Y, Tong Y, et al. (2012) Roles of Candida albicans Gat2, a GATA-type zinc finger transcription factor, in biofilm formation, filamentous growth and virulence. PLoS One 7: e29707. doi: 10.1371/journal.pone.0029707 22276126
32. Liu H, (2002) Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen. Int J Med Microbiol 292: 299–311. 12452278
33. Cheon SA, Jung KW, Chen YL, Heitman J, Bahn YS, et al. (2011) Unique evolution of the UPR pathway with a novel bZIP transcription factor, Hxl1, for controlling pathogenicity of Cryptococcus neoformans. PLoS Pathog 7: e1002177. doi: 10.1371/journal.ppat.1002177 21852949
34. Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, et al. (2010) Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans. FEMS Yeast Res 10: 587–596 doi: 10.1111/j.1567-1364.2010.00639.x 20491944